The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study.

PLoS One · 2013 · PMC3760872 · PMID 24019966

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

of borderline significanceP = 0.052so close (0.05 < p ≤ 0.1)

After adjusting for these variables, metformin monotherapy was of borderline significance ( P = 0.052), but sulfonylurea therapy and metformin in combination with a sulfonylurea were independently associated with a lower serum magnesium.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.